Gene-specific therapy for long QT syndrome: QT shortening with lidocaine and tocainide in patients with mutation of the sodium channel gene

Annals of Noninvasive Electrocardiology

Volumn 2, Issue 3, 1997, Pages 274-278

  Rosero, Spencer Z ^a   Zareba, Wojciech ^a   Robinson, Jennifer L ^a   Moss, Arthur J ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Cardiac sodium channel; Lidocaine; Long QT syndrome; Tocainide

Indexed keywords

LIDOCAINE; SODIUM CHANNEL; TOCAINIDE;

ADULT; ARTICLE; CASE REPORT; CHROMOSOME 3; DRUG EFFECT; GENE DELETION; GENE LOCATION; GENE MUTATION; GENE THERAPY; HEART REPOLARIZATION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LONG QT SYNDROME; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; QT INTERVAL;

EID: 0030791119     PISSN: 1082720X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1542-474X.1997.tb00336.x     Document Type: Article

References (20)

1. Moss AJ, Schwartz PJ, Crampton RS, et al. The long QT syndrome: Prospective longitudinal study of 328 families. Circulation 1991;84:1136-1144.
2. Keating MT, Atkinson D, Dunn C, et al. Linkage of a cardiac arrhythmia, the long QT syndrome, and the Harvey ras-1 gene. Science 1991;252:704-706.
3. Towbin JA, Li H, Taggart RT, et al. Evidence of genetic heterogeneity in Romano-Ward long QT syndrome: Analysis of 23 families. Circulation 1994;90:2635-2644.
4. Jiang C, Atkinson D, Towbin JA, et al. Two long QT syndrome loci map to chromosomes 3 and 7 with evidence for further heterogeneity. Nat Genet 1994;8:141-147.
5. Schott JJ, Charpentier F, Peltier S, et al. Mapping of a gene for long QT syndrome to chromosome 4q25-27. Am J Hum Genet 1995;57:1114-1122.
6. Moss AJ, Zareba W, Benhorin J, et al. ECG T-wave patterns in genetically distinct forms of the hereditary long QT syndrome. Circulation 1995;92:2929-2934.
7. Curran ME, Splawski I, Timothy KW, et al. A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome. Cell 1996; 80:795-803.
8. Wang Q, Shen J, Splawski I, et al. SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome. Cell 1995;80:805-811.
9. Wang Q, Curran ME, Splawski I, et al. Positional cloning of a novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmias. Nat Genet 1996; 12:17-23.
10. Sanguinetti MC, Curran ME, Zou A, et al. Coassembly of KvLQTl and MinK (IsK) proteins to form cardiac IKs potassium channel. Nature 1996;384(7)80-83.
11. Bennett PB, Yazawa K, Makita, et al. Molecular mechanism for an inherited cardiac arrhythmia. Nature 1995; 376:683685.
12. Dumaine R, Wang Q, Keating MT, et al. Multiple mechanisms of Na+ channel-linked long-QT syndrome. Cire Res 1996;78:916-924.
13. Cahalan MD, Almers W. Interactions between quaternary lidocaine, the sodium channel gates, and tetrodotoxin. Biophysj 1979;27:39-56.
14. Strichartz G. Effects of tertiary local anesthetics and their quaternary derivatives on sodium channels of nerve membranes. Froc Biophys J 1997; 18:353-354.
15. Schwartz PJ, Priori SG, Locati EH, et al. Long QT syndrome patients with mutations of the SCN5A and HERG genes have a differential response to Na+ channel blockade and to increases in heart rate. Circulation 1995;92:3381-3386.
16. An R-H, Bangalore R, Rosero SZ, et al. Lidocaine block of LQ.T-3 mutant human Na+ channels. Circ Res 1996; 79: 103-108.
17. Bazett HC. An analysis of the time relations of electrocardiograms. Heart 1920; 7:353-367.
18. Wang Q, Keating MT, Hartmann HA, et al. Biophysical phenotypes of mutant sodium channels in the chromosome 3-linked long QT syndrome, (abstract) Biophys J 1996; 70: A260.
19. Priori SG, Napolitano C, Cantu F, et al. Differential response to Na+ channel blockade, beta-adrenergic stimulation and rapid pacing in a cellular model mimicking the SCN5A and HERG defects present in the long-QT syndrome. Circ Res 1995;78:1009-1015.
20. Kass RS, Davies MP. The role of ion channels in an inherited heart disease: Molecular genetics of the long QT syndrome. Cardiovasc Res 1996; 32:443-454.